Prediction of in vivo bone forming potency of bone marrowderived human mesenchymal stem cells

European Cells and Materials

Volumn 21, Issue , 2011, Pages 488-507

  Janicki, Patricia ^a   Boeuf, Stephane ^a   Steck, Eric ^a   Egermann, Marcus ^a   Kasten, Philip ^b   Richter, Wiltrud ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Beta tricalciumphosphate; Bone tissue engineering; Cell proliferation; Heterotopic bone formation; Mesenchymal stem cell; Microarray; Prediction

Indexed keywords

CALCIUM PHOSPHATE; MITOMYCIN; ALKALINE PHOSPHATASE; BETA-TRICALCIUM PHOSPHATE; TISSUE SCAFFOLD;

ADOLESCENT; ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOSYNTHESIS; BONE DEVELOPMENT; BONE MINERALIZATION; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CHILD; CHROMATIN; CONTROLLED STUDY; FEMALE; GENE EXPRESSION PROFILING; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OSSIFICATION; OSTEOBLAST; PREDICTION; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; STEM CELL EXPANSION; UNINDEXED SEQUENCE; ANIMAL; BONE MARROW CELL; BONE REGENERATION; CELL CULTURE; CLUSTER ANALYSIS; CYTOLOGY; DRUG EFFECT; ENZYME ASSAY; MESENCHYMAL STEM CELL TRANSPLANTATION; METABOLISM; MIDDLE AGED; PHYSIOLOGY; XENOGRAFT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALKALINE PHOSPHATASE; ANIMALS; BONE MARROW CELLS; BONE REGENERATION; CALCIFICATION, PHYSIOLOGIC; CALCIUM PHOSPHATES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CHILD; CLUSTER ANALYSIS; ENZYME ASSAYS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MICE; MIDDLE AGED; MITOMYCIN; OSTEOGENESIS; TISSUE SCAFFOLDS; TRANSPLANTATION, HETEROLOGOUS; YOUNG ADULT;

EID: 79961136940     PISSN: 14732262     EISSN: None     Source Type: Journal    
DOI: 10.22203/ecm.v021a37     Document Type: Article

References (50)

1. Agata H, Asahina I, Watanabe N, Ishii Y, Kubo N, Ohshima S, Yamazaki M, Tojo A, Kagami H (2010) Characteristic change and loss of in vivo osteogenic abilities of human bone marrow stromal cells during passage. Tissue Eng Part A 16: 663-673.
2. Bruder SP, Kraus KH, Goldberg VM, Kadiyala S (1998a) The effect of implants loaded with autologous mesenchymal stem cells on the healing of canine segmental bone defects. J Bone Joint Surg Am 80: 985-996.
3. Bruder SP, Kurth AA, Shea M, Hayes WC, Jaiswal N, Kadiyala S (1998b) Bone regeneration by implantation of purifi ed, culture-expanded human mesenchymal stem cells. J Orthop Res 16: 155-162.
4. Caplan AI (2009) Why are MSCs therapeutic? New data: new insight. J Pathol 217: 318-324.
5. De Bari C, Dell'Accio F, Karystinou A, Guillot PV, Fisk NM, Jones EA, McGonagle D, Khan IM, Archer CW, Mitsiadis TA, Donaldson AN, Luyten FP, Pitzalis C (2008) A biomarker-based mathematical model to predict bone-forming potency of human synovial and periosteal mesenchymal stem cells. Arthritis Rheum 58: 240-250.
6. Dennis G, Jr., Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA (2003) DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 4: 3.
7. Dickhut A, Pelttari K, Janicki P, Wagner W, Eckstein V, Egermann M, Richter W (2009) Calcification or dedifferentiation: requirement to lock mesenchymal stem cells in a desired differentiation stage. J Cell Physiol 219: 219-226.
8. Digirolamo CM, Stokes D, Colter D, Phinney DG, Class R, Prockop DJ (1999) Propagation and senescence of human marrow stromal cells in culture: a simple colonyforming assay identifi es samples with the greatest potential to propagate and differentiate. Br J Haematol 107: 275-281.
9. Eisen MB, Spellman PT, Brown PO, Botstein D (1998) Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 95: 14863-14868.
10. Hernigou P, Mathieu G, Poignard A, Manicom O, Beaujean F, Rouard H (2006) Percutaneous autologous bone-marrow grafting for nonunions. Surgical technique. J Bone Joint Surg Am 88 Suppl 1: 322-327.
11. Huang DW, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44-57.
12. Jaiswal N, Haynesworth SE, Caplan AI, Bruder SP (1997) Osteogenic differentiation of purifi ed, cultureexpanded human mesenchymal stem cells in vitro. J Cell Biochem 64: 295-312.
13. Janicki P, Kasten P, Kleinschmidt K, Luginbuehl R, Richter W (2010) Chondrogenic pre-induction of human mesenchymal stem cells on beta-TCP: enhanced bone quality by endochondral heterotopic bone formation. Acta Biomater 6: 3292-3301.
14. Jensen SS, Broggini N, Hjorting-Hansen E, Schenk R, Buser D (2006) Bone healing and graft resorption of autograft, anorganic bovine bone and beta-tricalcium phosphate. A histologic and histomorphometric study in the mandibles of minipigs. Clin Oral Implants Res 17: 237-243.
15. Krebsbach PH, Kuznetsov SA, Satomura K, Emmons RV, Rowe DW, Robey PG (1997) Bone formation in vivo: comparison of osteogenesis by transplanted mouse and human marrow stromal fi broblasts. Transplantation 63: 1059-1069.
16. Kuznetsov SA, Mankani MH, Robey PG (2000) Effect of serum on human bone marrow stromal cells: ex vivo expansion and in vivo bone formation. Transplantation 70: 1780-1787.
17. Larsen KH, Frederiksen CM, Burns JS, Abdallah BM, Kassem M (2010) Identifying a molecular phenotype for bone marrow stromal cells with in vivo bone-forming capacity. J Bone Miner Res 25: 796-808.
18. Lazarus HM, Haynesworth SE, Gerson SL, Caplan AI (1997) Human bone marrow-derived mesenchymal (stromal) progenitor cells (MPCs) cannot be recovered from peripheral blood progenitor cell collections. J Hematother 6: 447-455.
19. Majors AK, Boehm CA, Nitto H, Midura RJ, Muschler GF (1997) Characterization of human bone marrow stromal cells with respect to osteoblastic differentiation. J Orthop Res 15: 546-557.
20. Mannello F, Tonti GA (2007) Concise review: no breakthroughs for human mesenchymal and embryonic stem cell culture: conditioned medium, feeder layer, or feeder-free; medium with fetal calf serum, human serum, or enriched plasma; serum-free, serum replacement nonconditioned medium, or ad hoc formula? All that glitters is not gold! Stem Cells 25: 1603-1609.
21. Martin I, Muraglia A, Campanile G, Cancedda R, Quarto R (1997) Fibroblast growth factor-2 supports ex vivo expansion and maintenance of osteogenic precursors from human bone marrow. Endocrinology 138: 4456-4462.
22. Matsushima A, Kotobuki N, Tadokoro M, Kawate K, Yajima H, Takakura Y, Ohgushi H (2009) In vivo osteogenic capability of human mesenchymal cells cultured on hydroxyapatite and on beta-tricalcium phosphate. Artif Organs 33: 474-481.
23. McLain RF, Fleming JE, Boehm CA, Muschler GF (2005) Aspiration of osteoprogenitor cells for augmenting spinal fusion: comparison of progenitor cell concentrations from the vertebral body and iliac crest. J Bone Joint Surg Am 87: 2655-2661.
24. Mendes SC, Tibbe JM, Veenhof M, Bakker K, Both S, Platenburg PP, Oner FC, de Bruijn JD, van Blitterswijk CA (2002) Bone tissue-engineered implants using human bone marrow stromal cells: effect of culture conditions and donor age. Tissue Eng 8: 911-920.
25. Mendes SC, Tibbe JM, Veenhof M, Both S, Oner FC, van Blitterswijk CA, de Bruijn JD (2004) Relation between in vitro and in vivo osteogenic potential of cultured human bone marrow stromal cells. J Mater Sci Mater Med 15: 1123-1128.
26. Metz CE, Goodenough DJ, Rossmann K (1973) Evaluation of receiver operating characteristic curve data in terms of information theory, with applications in radiography. Radiology 109: 297-303.
27. Muraglia A, Martin I, Cancedda R, Quarto R (1998) A nude mouse model for human bone formation in unloaded conditions. Bone 22: 131S-134S.
28. Muschler GF, Boehm C, Easley K (1997) Aspiration to obtain osteoblast progenitor cells from human bone marrow: the infl uence of aspiration volume. J Bone Joint Surg Am 79: 1699-1709.
29. Muschler GF, Nitto H, Boehm CA, Easley KA (2001) Age- and gender-related changes in the cellularity of human bone marrow and the prevalence of osteoblastic progenitors. J Orthop Res 19: 117-125.
30. Okuda T, Ioku K, Yonezawa I, Minagi H, Kawachi G, Gonda Y, Murayama H, Shibata Y, Minami S, Kamihira S, Kurosawa H, Ikeda T (2007) The effect of the microstructure of beta-tricalcium phosphate on the metabolism of subsequently formed bone tissue. Biomaterials 28: 2612-2621.
31. Phinney DG (2002) Building a consensus regarding the nature and origin of mesenchymal stem cells. J Cell Biochem Suppl 38: 7-12.
32. Phinney DG (2007) Biochemical heterogeneity of mesenchymal stem cell populations: clues to their therapeutic effi cacy. Cell Cycle 6: 2884-2889.
33. Phinney DG, Kopen G, Righter W, Webster S, Tremain N, Prockop DJ (1999) Donor variation in the growth properties and osteogenic potential of human marrow stromal cells. J Cell Biochem 75: 424-436.
34. Pietila M, Lehtonen S, Narhi M, Hassinen IE, Leskela HV, Aranko K, Nordstrom K, Vepsalainen A, Lehenkari P (2010) Mitochondrial function determines the viability and osteogenic potency of human mesenchymal stem cells. Tissue Eng Part C Methods 16: 435-445.
35. Platt MO, Wilder CL, Wells A, Griffith LG, Lauffenburger DA (2009) Multipathway kinase signatures of multipotent stromal cells are predictive for osteogenic differentiation: tissue-specifi c stem cells. Stem Cells 27: 2804-2814.
36. Reyes M, Lund T, Lenvik T, Aguiar D, Koodie L, Verfaillie CM (2001) Purifi cation and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood 98: 2615-2625.
37. Rickard DJ, Kassem M, Hefferan TE, Sarkar G, Spelsberg TC, Riggs BL (1996) Isolation and characterization of osteoblast precursor cells from human bone marrow. J Bone Miner Res 11: 312-324.
38. Russell KC, Phinney DG, Lacey MR, Barrilleaux BL, Meyertholen KE, O'Connor KC (2010) In vitro highcapacity assay to quantify the clonal heterogeneity in trilineage potential of mesenchymal stem cells reveals a complex hierarchy of lineage commitment. Stem Cells 28: 788-798.
39. Shahdadfar A, Fronsdal K, Haug T, Reinholt FP, Brinchmann JE (2005) In vitro expansion of human mesenchymal stem cells: choice of serum is a determinant of cell proliferation, differentiation, gene expression, and transcriptome stability. Stem Cells 23: 1357-1366.
40. Siddappa R, Licht R, van Blitterswijk C, de Boer J (2007) Donor variation and loss of multipotency during in vitro expansion of human mesenchymal stem cells for bone tissue engineering. J Orthop Res 25: 1029-1041.
41. Siddappa R, Martens A, Doorn J, Leusink A, Olivo C, Licht R, van Rijn L, Gaspar C, Fodde R, Janssen F, van Blitterswijk C, de Boer J (2008) cAMP/PKA pathway activation in human mesenchymal stem cells in vitro results in robust bone formation in vivo. Proc Natl Acad Sci USA 105: 7281-7286.
42. Sotiropoulou PA, Perez SA, Salagianni M, Baxevanis CN, Papamichail M (2006) Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells. Stem Cells 24: 462-471.
43. Steck E, Burkhardt M, Ehrlich H, Richter W (2010) Discrimination between cells of murine and human origin in xenotransplants by species specifi c genomic in situ hybridization. Xenotransplantation 17: 153-159.
44. Stenderup K, Justesen J, Clausen C, Kassem M (2003) Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone 33: 919-926.
45. Stolzing A, Jones E, McGonagle D, Scutt A (2008) Age-related changes in human bone marrow-derived mesenchymal stem cells: consequences for cell therapies. Mech Ageing Dev 129: 163-173.
46. Tarte K, Gaillard J, Lataillade JJ, Fouillard L, Becker M, Mossafa H, Tchirkov A, Rouard H, Henry C, Splingard M, Dulong J, Monnier D, Gourmelon P, Gorin NC, Sensebe L (2010) Clinical-grade production of human mesenchymal stromal cells: occurrence of aneuploidy without transformation. Blood 115: 1549-1553.
47. Wagner W, Ho AD (2007) Mesenchymal stem cell preparations - comparing apples and oranges. Stem Cell Rev 3: 239-248.
48. Winter A, Breit S, Parsch D, Benz K, Steck E, Hauner H, Weber RM, Ewerbeck V, Richter W (2003) Cartilagelike gene expression in differentiated human stem cell spheroids: a comparison of bone marrow-derived and adipose tissue-derived stromal cells. Arthritis Rheum 48: 418-429.
49. Zweig MH, Campbell G (1993) Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 39: 561-577.
50. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop Dj, Horwitz E (2006) Minimal criteria for defi ning multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8: 315-317.